Search Results
Showing Results for glaucoma,
What if your medical degree could launch more than a clinical career? In this candid and compelling read, Dr Jon Edelson shares his lessons for early-career clinicians ready to think beyond the bedside and explore the business of medicine.
The European Commission has granted market authorization for Ryjunea®, a low-dose atropine eye drop developed by Santen Pharmaceutical Co., Ltd., For the first time in Europe, children struggling with worsening vision have a clinically proven treatment to slow myopia
We are delighted to share the latest issue of touchREVIEWS in Ophthalmology, showcasing a diverse range of articles that highlight the innovation, interdisciplinary collaboration and continued advances driving progress in eye care today. We begin this issue with an important ...
Taking place from 7–9 June 2025 in Lisbon, Portugal, the SOE Congress is one of Europe's leading multi-specialty ophthalmology meetings. With a world-class scientific programme, this in-person event offers a rich mix of symposia, live surgery, debates, workshops, mystery cases and updates ...
In this episode, we explore the future of continuing medical education (CME) with the team behind touchIME. Hannah Fisher and Matthew Goodwin share insights into global and US trends, the importance of patient inclusivity and how educational outcomes are evolving to better measure the direct impact of learning on clinical practice and patient care.
Breast carcinoma is the most common cancer in females. An estimated 2.3 million new cases of breast carcinoma are diagnosed annually worldwide.1Â These patients have potential risks of ocular complications not only from the secondaries in the eye but also due ...
This episode explores the inspiring work of Orbis International, a nonprofit preventing blindness and restoring sight in underserved communities. Dr Maria Berrocal, Associate Professor and Orbis Volunteer Faculty, shares her experience aboard the Orbis Flying Eye Hospital, a fully equipped surgical and teaching hospital on an aircraft, and discusses the importance of global collaboration in building sustainable, high-quality eye care systems around the world.
In this Q&A session, Dr Vinciguerra reflects on the key highlights of his career, the mentors who have influenced his journey, and his aspirations for the future.
Since its inception in November 2022, ChatGPT-3.5 has gained increasing popularity.1,2 ChatGPT is an artificial intelligence (AI) language application that performs online tasks and mimics human conversations using a question-and-answer format.3Â The interface has found widespread use in several industries, with ...
Glaucoma is life-changing. During Glaucoma Awareness Month this January, the Glaucoma Foundation (TGF) is bringing a spotlight to patients and others who are tackling this disease. How are they struggling? How are they thriving?Â
As we eagerly await the innovations and breakthroughs that 2025 promises ophthalmlology, we reached out to some of our esteemed editorial board members to share their insights.
As 2024 draws to a close, we’re celebrating a remarkable year of content.
We have seen plenty of innovation in ophthalmology, with researchers and clinicians making significant strides in how eye conditions are treated and managed. From improving drug delivery methods to harnessing the potential of gene and stem cell therapies, 2024 has been a year of promising progress across multiple areas. As we edge closer to 2025, we are eager to see what advancements will further improve vision and eye care. To envision what lies ahead, we turn to our expert editorial board to share their insights on the developments shaping the future of ophthalmology:
The World Glaucoma Association (WGA) is thrilled to announce the 11th World Glaucoma Congress, scheduled for June 25-28, 2025, in Honolulu, Hawaii, USA. Held biennially, the WGC is the largest international meeting dedicated to glaucoma, providing a platform for young researchers to present their work and gain recognition within the global glaucoma community.
The uvea is a vascular stratum that includes the iris, ciliary body and choroid. Uveitis is defined as inflammation of a part of the uvea or its entirety, but it is also used to describe inflammatory processes of any part ...
The American Society of Cataract and Refractive Surgery (ASCRS) annual meeting, held this year in San Diego, has once again showcased the latest and most exciting advancements in the field of ophthalmology. Bringing together top experts, researchers and practitioners, this year's meeting was a hub of innovation and knowledge-sharing. Among the many insightful presentations and cutting-edge technologies, a few developments stood out as particularly noteworthy. In this article, we highlight some of the most exciting breakthroughs from ASCRS 2024 that could shape the future of eye care.
The European Society of Cataract and Refractive Surgeons (ESCRS) is gearing up for its 42nd Congress, scheduled to take place from September 6-10, 2024, at the Fira de Barcelona in Spain. This prestigious event promises to be a hub of innovation and knowledge-sharing in ophthalmology.
Log into your Touch Account
Earn and track your CME credits on the go, save articles for later, and follow the latest congress coverage.
Sign up with an Email
Or use a .
This Functionality is for
Members Only
Explore the latest in medical education and stay current in your field. Create a free account to track your learning.
